Lv61
2600 积分 2023-08-25 加入
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial
5小时前
已完结
Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial
8天前
已完结
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
8天前
已完结
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
8天前
已完结
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial
8天前
已完结
乳头腺瘤的诊断与手术治疗
11天前
已完结
16例乳头腺瘤的临床诊治分析
11天前
已完结
中西医结合临床诊疗乳腺增生专家共识
14天前
已完结
中国女性乳腺分叶状肿瘤诊治专家共识
1个月前
已完结
皖公网安备34019202002308
